Clinical Trials, Phase I as Topic (ethics) < Clinical Trials, Phase II as Topic < Clinical Trials, Phase III as Topic (statistics & numerical data) | Facettes : |
List of bibliographic references indexed by Clinical Trials, Phase II as Topic
Number of relevant bibliographic references: 3.Ident. | Authors (with country if any) | Title |
---|---|---|
000474 (2015) | Tiago A. Mestre [Canada] ; Isabelle Beaulieu-Boire [Canada] ; Camila C. Aquino [Canada] ; Nicolas Phielipp [États-Unis] ; Yu Yan Poon [Canada] ; Jane P. Lui [Canada] ; Julie So [Canada] ; Susan H. Fox [Canada] | What is a clinically important change in the Unified Dyskinesia Rating Scale in Parkinson's disease? |
000493 (2015) | Marcus W. Koch [Canada] ; Lawrence Korngut [Canada] ; David G. Patry [Canada] ; Yahya Agha-Khani [Canada] ; Christopher White [Canada] ; Justyna R. Sarna [Canada] ; Michael Yeung [Canada] ; V Wee Yong [Canada] ; Daniel Y C. Heng [Canada] ; Gary Cutter [États-Unis] ; Luanne Metz [Canada] | The promise of futility trials in neurological diseases. |
002D76 (2003) | Iometopane: (123)I beta-CIT, dopascan injection, GPI 200, RTI 55. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Clinical Trials, Phase II as Topic"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i \ -Sk "Clinical Trials, Phase II as Topic" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Canada |area= ParkinsonCanadaV1 |flux= Main |étape= Exploration |type= indexItem |index= KwdEn.i |clé= Clinical Trials, Phase II as Topic }}
This area was generated with Dilib version V0.6.29. |